EUVIMEDAtklāt EUVIMED
CrossrefInformācijas karte

Medical and advanced heart failure therapies in Türkiye

SANEM NALBANTGİL, EMRE DEMİR, AHMET ÇELİK, İNCİ TUĞÇE ÇÖLLÜOĞLU, NAİM ATA, MEHMET BİRHAN YILMAZ, ANIL ŞAHİN, DİLEK URAL, MUSTAFA MAHİR ÜLGÜ, EMİNE ARZU KANIK, LALE DİNÇ ASARCIKLI, YÜKSEL ÇAVUŞOĞLU, SELDA MURAT, ŞUAYİP BİRİNCİ

Turkish Journal of Medical Sciences · 2024-01-01 · 54 (7) · 1470-1477

DOI: 10.55730/1300-0144.5933 ↗
AbstraktsBibliogrāfiskie dati

Abstrakts

Background/aim: Effective management of heart failure involves evidence-based use of multiple medications and their combinations. Furthermore, dosage escalation of the recommended medications is advised. In cases of advanced heart failure, long-term mechanical assistance devices or heart transplantation surgery may be necessary. The socio-economic situation creates unequal chances for people to access these treatments.The study aimed to analyze and compare medical and advanced heart failure treatments recommended by guidelines across various regions in Türkiye.Materials and methods: About 85 million citizen medical treatment records were utilized between January 1, 2016, and December 31, 2022. Medical and heart replacement treatment opportunities used in heart failure in Türkiye were evaluated in the general population and different geographical regions.Results: According to this study, beta-blockers were the most commonly prescribed medication for heart failure in Türkiye. This was followed by angiotensin-converting enzyme inhibitors (ACEi) at 44% and mineralocorticoid receptor antagonists (MRA) at 38.9%. However, only 0.6% of patients used angiotensin receptor blocker-neprilysin inhibitors (ARNI). Despite the high incidence of diabetes mellitus among heart failure patients, only 11% used sodium-glucose cotransporter two inhibitors (SGLT-2i). The study also found that using an Implantable Cardioverter Defibrillator (ICD) was 0.8%, and Cardiac Resynchronization Therapy (CRT) was 0.3% among all intracardiac device treatments. Heart replacement therapies, cardiac transplantation surgery, and long-term left ventricle-assisted device (LVAD) surgery had very low rates.Conclusion: The use of guideline-directed medical therapy is not optimal in Türkiye. Also, it differs within different geographical regions. It is a fact that heart transplant or LVAD surgery, CRT, and ICD implantation rates in Türkiye are significantly lower than in developed countries, regardless of geographical regions.

Jūsu darbam piemērotas zināšanas.

No bezmaksas sākuma un personīgās literatūras meklēšanas līdz pilnam Research Suite.

Skatīt tarifus →

Vai ir iekļauti visi izdevēju pilnteksti?

Nē. Bibliogrāfiskie ieraksti, kopsavilkumi un pilnteksti ir atšķirīgs saturs. Tas, vai pilnteksts ir pieejams, ir atkarīgs no avota, Open Access un jūsu esošajām licencēm. EUVIMED tarifs neaizstāj papildu izdevēju tiesības.

Skatīt tarifus →